Met Life Investment Management, LLC Third Harmonic Bio, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 12,859 shares of THRD stock, worth $44,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,859
Previous 12,859
-0.0%
Holding current value
$44,620
Previous $174,000
24.14%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding THRD
# of Institutions
93Shares Held
40.2MCall Options Held
100Put Options Held
0-
Atlas Venture Life Science Advisors, LLC10.4MShares$36.1 Million17.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$20.1 Million1.61% of portfolio
-
General Atlantic LLC New York, NY3.37MShares$11.7 Million1.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$11 Million1.53% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.93MShares$10.2 Million0.02% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $140M